Global Biotechnology Market Opportunities and Forecast 2023-2030

  • DLR2521
  • August, 2021
  • Pages: 120
  • Global
Biotechnology Market Overview

Biotechnology is a science-driven industry sector that uses living organisms and molecular biology to produce healthcare-related products. Biotechnology is best known for its role in medicine and pharmaceuticals, but the science is also applied in other areas such as genomics, food production, and the production of biofuels.

The increasing demand for modern and innovative technologies such as DNA sequencing, recombinant technology, fermentation, tissue engineering is primarily boosting the growth of the global Biotechnology market. In addition, the growing demand for food to meet the need of the ever-increasing population and scarce availability of non-renewable natural resources further escalate the growth of the Biotechnology market. The application of Genetic engineering and Genetic Modification (GM) processes to agricultural food products is also projected to drive the growth of the market. Moreover, the development of novel techniques and their implementation by the organization will propel the growth of the Biotechnology Market.

Furthermore, the growing demand for therapeutic and diagnostic solutions on principles of red biotechnology, DNA sequencing, and recombinant technology is projected to boost the growth of the global Biotechnology market in the next few years. In addition to this, the rising incidence of diseases such as hepatitis B, cancer, and other orphan disorders is also anticipated to fuel demand in the coming years. Additionally, reducing the prices of DNA sequencing technologies will encourage R&D activities to better understand genetic variations and develop therapeutic solutions.

Covid-19 Impact on Biotechnology Market

In addition, the current Biotechnology Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Biotechnology Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Biotechnology Market Segment Overview

Based on Technology, the DNA Sequencing segment held the largest share of the global Biotechnology market in 2020. The strong growth of this segment can be attributed to the rising adoption of advanced DNA sequencing. For instance, in April 2020, the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) received a grant from the National Institutes of Health for Pacific Biosciences Sequel II DNA sequencing instrument. It will help in improving sequencing efficiency and capacity. Moreover, the Health application segment held the maximum share of the market in 2020 and it is projected to continue this lead over the forecast period. The growth of this segment can be mainly attributed to the growing incidence of diseases. Additionally, rising focus on agri-biotech and providing bio-services, increasing adoption of bioinformatics solutions, and flourishing bio-industrial sector are majorly contributing to the growth of this segment.

Biotechnology Market, By Technology

·       Nanobiotechnology
·       Tissue Engineering and Regeneration
·       DNA Sequencing
·       Cell-based Assays
·       Fermentation
·       PCR Technology
·       Chromatography
·       Others

Biotechnology Market, By Application

·       Health
·       Food & Agriculture
·       Natural Resources & Environment
·       Industrial Processing
·       Bioinformatics
·       Others

Biotechnology Market Regional Overview

Region-wise, North America accounts for a major share in the Biotechnology market. The growth of the regional market can be attributed to the presence of key players, widespread R&D activities, and high healthcare expenditure. Also, expanding pool of companies operating in the region is receiving drug approvals, which further contribute to the market growth progressively. On the other hand, Asia Pacific is likely to exhibit a strong CAGR throughout the forecast period. Important factors such as developing healthcare infrastructure, favorable government policies, clinical trial services, and epidemiological factors are significantly propelling the growth of the market in this region.

Biotechnology Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Biotechnology Market, Key Players

·       AstraZeneca
·       Gilead Sciences, Inc.  
·       CELGENE CORPORATION
·       Biogen
·       Abbott
·       Amgen Inc.
·       Novo Nordisk A/S
·       Merck & Co.
·       Johnson & Johnson Services, Inc.
·       Novartis AG
·       Sanofi
·       F. Hoffmann-La Roche Ltd.
·       Pfizer, Inc.
·       Lonza

 

Biotechnology Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Biotechnology Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Technology
        • 5.2.1. Nanobiotechnology
        • 5.2.2. Tissue Engineering and Regeneration
        • 5.2.3. DNA Sequencing
        • 5.2.4. Cell-based Assays
        • 5.2.5. Fermentation
        • 5.2.6. PCR Technology
        • 5.2.7. Chromatography
        • 5.2.8. Others
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Health
        • 5.3.2. Food & Agriculture
        • 5.3.3. Natural Resources & Environment
        • 5.3.4. Industrial Processing
        • 5.3.5. Bioinformatics
        • 5.3.6. Others
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America Biotechnology Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Technology
        • 6.2.1. Nanobiotechnology
        • 6.2.2. Tissue Engineering and Regeneration
        • 6.2.3. DNA Sequencing
        • 6.2.4. Cell-based Assays
        • 6.2.5. Fermentation
        • 6.2.6. PCR Technology
        • 6.2.7. Chromatography
        • 6.2.8. Others
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Health
        • 6.3.2. Food & Agriculture
        • 6.3.3. Natural Resources & Environment
        • 6.3.4. Industrial Processing
        • 6.3.5. Bioinformatics
        • 6.3.6. Others
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Biotechnology Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Technology
        • 7.2.1. Nanobiotechnology
        • 7.2.2. Tissue Engineering and Regeneration
        • 7.2.3. DNA Sequencing
        • 7.2.4. Cell-based Assays
        • 7.2.5. Fermentation
        • 7.2.6. PCR Technology
        • 7.2.7. Chromatography
        • 7.2.8. Others
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Health
        • 7.3.2. Food & Agriculture
        • 7.3.3. Natural Resources & Environment
        • 7.3.4. Industrial Processing
        • 7.3.5. Bioinformatics
        • 7.3.6. Others
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Biotechnology Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Technology
        • 8.2.1. Nanobiotechnology
        • 8.2.2. Tissue Engineering and Regeneration
        • 8.2.3. DNA Sequencing
        • 8.2.4. Cell-based Assays
        • 8.2.5. Fermentation
        • 8.2.6. PCR Technology
        • 8.2.7. Chromatography
        • 8.2.8. Others
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Health
        • 8.3.2. Food & Agriculture
        • 8.3.3. Natural Resources & Environment
        • 8.3.4. Industrial Processing
        • 8.3.5. Bioinformatics
        • 8.3.6. Others
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Biotechnology Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Technology
        • 9.2.1. Nanobiotechnology
        • 9.2.2. Tissue Engineering and Regeneration
        • 9.2.3. DNA Sequencing
        • 9.2.4. Cell-based Assays
        • 9.2.5. Fermentation
        • 9.2.6. PCR Technology
        • 9.2.7. Chromatography
        • 9.2.8. Others
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Health
        • 9.3.2. Food & Agriculture
        • 9.3.3. Natural Resources & Environment
        • 9.3.4. Industrial Processing
        • 9.3.5. Bioinformatics
        • 9.3.6. Others
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. AstraZeneca
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Gilead Sciences, Inc.
      • 10.6. CELGENE CORPORATION
      • 10.7. Biogen
      • 10.8. Abbott
      • 10.9. Amgen Inc.
      • 10.10. Novo Nordisk A/S
      • 10.11. Merck & Co.
      • 10.12. Johnson & Johnson Services, Inc.
      • 10.13. Novartis AG
      • 10.14. Sanofi
      • 10.15. F. Hoffmann-La Roche Ltd.
      • 10.16. Pfizer, Inc.
      List of Figures

      Figure 1: Global Biotechnology Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Biotechnology Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Biotechnology Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Biotechnology Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Biotechnology Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Biotechnology Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Biotechnology Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Biotechnology Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Biotechnology Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Biotechnology Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Biotechnology Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Biotechnology Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Biotechnology Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Biotechnology Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Biotechnology Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Biotechnology Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Biotechnology Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Biotechnology Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Biotechnology Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Biotechnology Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Biotechnology Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Biotechnology Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Biotechnology Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Biotechnology Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Biotechnology Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Biotechnology Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Biotechnology Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Biotechnology Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Biotechnology Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Biotechnology Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Biotechnology Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Biotechnology Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Biotechnology Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Biotechnology Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Biotechnology Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Biotechnology Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Biotechnology Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Biotechnology Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Biotechnology Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Biotechnology Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Biotechnology Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Biotechnology Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Biotechnology Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Biotechnology Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Biotechnology Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Biotechnology Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Biotechnology Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Biotechnology Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Biotechnology Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Biotechnology Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Biotechnology Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Biotechnology Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Biotechnology Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Biotechnology Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Biotechnology Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Biotechnology Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Biotechnology Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Biotechnology Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Biotechnology Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Biotechnology Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Biotechnology Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Biotechnology Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Biotechnology Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Biotechnology Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Biotechnology Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Research Process

      Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.

      In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization

      FIGURE 1: DLR RESEARH PROCESS

      research-methodology1

      Primary Research

      Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.

      In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.

      It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

      Secondary Research

      Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.

      Market Size Estimation

      Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.

      Forecast Model

      research-methodology2

      Happy to Assist You

      If you have a question?

      [email protected]

      IND : +91 955 279 0357

      Browse Related Reports